Qingdao NovelBeam Technology Co. Ltd. A (688677.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100005410

Price
50.88 CNY
Market cap
6.06 bn CNY
P/E (2025)
35.33
P/S (2025)
10.06
Dividend yield
1.18 %
Net margin
28.48 %
Return on equity (ROE)
12.74 %
Return on assets (ROA)
10.50 %

Qingdao NovelBeam Technology Co. Ltd. A financials

Fiscal year20242025
Revenue442.83 m CNY602.61 m CNY
Gross profit280.07 m CNY602.61 m CNY
Operating income152.94 m CNY190.01 m CNY
EBIT152.99 m CNY191.17 m CNY
Net income135.35 m CNY171.60 m CNY
Diluted EPS – continuing operations1.12 CNY1.44 CNY

Full history since 2013, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Qingdao NovelBeam Technology Co. Ltd. A

Qingdao NovelBeam Technology Co.,Ltd. engages in the research and development, production, sales, and service of medical endoscopic instruments and optical products in China and internationally. The company offers IV endoscopic surgery workstation, camera system, LED cold light source, and laparoscope; OV clinic and surgery workstation; and optics products. It also provides endoscope, light source, camera system, surgical imaging system, endoscopic system, and operation room visualization solutions; optical components, optomechanical modules, and integrated systems; and technical support and value-added services. Its products are used in clinical surgery, analytical diagnostics, industrial applications, and lasers. The company was founded in 2003 and is headquartered in Qingdao, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.